A pilot study of prospective resigstry to evaluate the safety and efficacy of ultrasound-guided pharmacopuncture for spinal disorders
This study aims to evaluate the safety and efficacy of ultrasound-guided pharmacopuncture by collecting information on adverse reactions, efficacy assessment variables, and treatment methods from patients diagnosed with spinal disorders who have undergone ultrasound-guided pharmacopuncture treatment.
Study Type
OBSERVATIONAL
Enrollment
50
Pharmacopuncture treatment using ultrasound-guidance
Jaseng Hospital of Korean medicine
Seoul, Gangnam-Gu, South Korea
Bucheon Jaseng Hospital of Korean Medicine
Bucheon-si, Gyeonggi Province, South Korea
Daejeon Jaseng Hospital of Korean medicine
Daejeon, Seo-gu, South Korea
Adverse Event
Adverse events assessment
Time frame: Treatment visits up to 12 weeks, and Week 2, 4, 8, 12 follow-ups
Spinal pain numeric rating scale
Spinal pain numeric rating scale
Time frame: Week 0, Treatment visits up to 12 weeks, and Week 2, 4, 8, 12 follow-ups
Disability index
Neck disability index or Oswestry Disability Index
Time frame: Week 0, 2, 4, 8, 12
EQ-5D-5L
Quality of life using EQ-5D-5L
Time frame: Week 0, 2, 4, 8, 12
Patient satisfaction
Patient satisfaction survey
Time frame: Week 4
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.